Exane Derivatives’s McKesson MCK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,744
Closed -$534K 874
2022
Q1
$534K Sell
1,744
-295
-14% -$80.2K 0.15% 179
2021
Q4
$507K Sell
2,039
-905
-31% -$199K 0.12% 174
2021
Q3
$587K Buy
2,944
+1,809
+159% +$362K 0.14% 155
2021
Q2
$215K Sell
1,135
-2,896
-72% -$559K 0.05% 376
2021
Q1
$786K Buy
4,031
+2,674
+197% +$488K 0.22% 98
2020
Q4
$236K Sell
1,357
-5,368
-80% -$894K 0.07% 286
2020
Q3
$1M Buy
6,725
+6,384
+1,872% +$969K 0.29% 81
2020
Q2
$52.3K Sell
341
-15,821
-98% -$2.28M 0.01% 349
2020
Q1
$2.19M Buy
16,162
+16,130
+50,406% +$2.36M 0.61% 39
2019
Q4
$4.93K Sell
32
-23,283
-100% -$3.29M ﹤0.01% 439
2019
Q3
$3.19M Buy
23,315
+22,707
+3,735% +$3.22M 0.57% 52
2019
Q2
$81.7K Sell
608
-31,271
-98% -$3.9M 0.01% 353
2019
Q1
$3.73M Buy
31,879
+31,604
+11,492% +$3.9M 0.74% 43
2018
Q4
$30.4K Hold
275
0.01% 412
2018
Q3
$36.3K Buy
275
+267
+3,338% +$34.8K 0.01% 385
2018
Q2
$1.08K Hold
8
﹤0.01% 522
2018
Q1
$1.12K Sell
8
-15
-65% -$2.34K ﹤0.01% 467
2017
Q4
$3.59K Sell
23
-67
-74% -$9.93K ﹤0.01% 439
2017
Q3
$13.8K Sell
90
-26
-22% -$4.06K ﹤0.01% 377
2017
Q2
$19.1K Hold
116
﹤0.01% 366
2017
Q1
$17.2K Sell
116
-147
-56% -$21.5K ﹤0.01% 332
2016
Q4
$36.9K Hold
263
0.01% 316
2016
Q3
$43.8K Sell
263
-159
-38% -$29.6K 0.01% 312
2016
Q2
$78.8K Sell
422
-8
-2% -$1.4K 0.01% 253
2016
Q1
$67.6K Buy
430
+43
+11% +$6.95K 0.01% 274
2015
Q4
$76.3K Sell
387
-93,692
-100% -$17.7M 0.01% 235
2015
Q3
$17.4M Buy
+94,079
New +$19.9M 2.2% 22

Other funds holding MCK

Exane Derivatives's MCK Position: Q2 2022 in Review

Exane Derivatives sold out of McKesson (MCK) in Q2 2022, closing a stake of 1,744 shares — an estimated $534K sold.

Exane Derivatives first reported a position in MCK in Q3 2015 and held it in 27 quarters. The position peaked at $17.4M in Q3 2015. 1,168 funds tracked by Wall St. Rank hold MCK as of Q2 2022.

  • Exane Derivatives reported no remaining McKesson position as of Q2 2022 after selling out during the quarter.
  • Exane Derivatives sold 1,744 McKesson shares in Q2 2022, an estimated $534K.
  • Exane Derivatives first reported a position in McKesson in Q3 2015 and held it in 27 quarters.
  • Exane Derivatives's McKesson position peaked at $17.4M in Q3 2015.
  • 1,168 funds tracked by Wall St. Rank held McKesson as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.